4/A: Teladoc Health Amends Executive Stock Unit Disclosure

Teladoc Health, Inc. filed an amended Form 4 to correct the number of performance stock units awarded to President Kelly Bliss.

Summary

• An amendment to a Form 4 was filed, originally submitted on March 3, 2026.
• The amendment corrects an inadvertent error in the number of performance stock units (PSUs) awarded to Kelly Bliss, President, U.S. Group Health.
• The correct number of PSUs awarded on February 27, 2026, is 15,596.
• Each performance stock unit represents a contingent right to receive one share of Teladoc Health common stock.
• The performance award amount was determined based on metrics related to Teladoc Health's 2025 financial results.
• One-third of the performance stock units (approximately 5,198 units) vested on March 1, 2026.
• The remaining 10,398 units are scheduled to vest in eight substantially equal quarterly installments thereafter.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as neutral. While an initial administrative error occurred, the prompt correction demonstrates adherence to disclosure requirements, and the underlying executive compensation award is a standard practice.

Positives

• The amendment provides accurate and transparent disclosure of executive compensation details.
• The award of 15,596 performance stock units to a key executive, Kelly Bliss, aligns management incentives with the company's performance.

Negatives

• An initial administrative error occurred in the original Form 4 filing regarding the number of performance stock units awarded.

Future Outlook

The remaining 10,398 performance stock units will vest in eight substantially equal quarterly installments following March 1, 2026, indicating future share issuance tied to executive compensation.

Industry Context

StockSavvy.ai notes that accurate and timely disclosure of executive compensation is a standard regulatory requirement, ensuring transparency for investors. This amendment corrects a minor administrative error in such a disclosure, which is a routine compliance action.

Stakeholder Impact

• Shareholders: Provides accurate information on executive compensation, ensuring transparency and clarity regarding equity awards.
• Executive (Kelly Bliss): Confirms the correct number of performance stock units awarded, aligning personal incentives with company performance and clarifying future equity holdings.

Next Steps

• Future vesting of the remaining 10,398 performance stock units in eight substantially equal quarterly installments.

Key Dates

Recommendation

This Form 4/A is an administrative correction of an executive's performance stock unit award and does not contain information that would fundamentally alter the investment outlook for Teladoc Health, Inc. The underlying award itself is a standard executive compensation practice, and the correction does not introduce new material information to warrant a change in investment thesis.

Keywords

Teladoc Health, TDOC, SEC filing, Form 4/A, performance stock units, executive compensation, Kelly Bliss, stock award, vesting